glp-1 news past 3 days GLP-1-directed NMDA receptor antagonism for obesity treatment GLP-1 Drugs: 6 Things We've

The strength of the anti-addictive effect of GLP-1s appears so clear that many physicians are already using these treatments for patients with substance use disorders (SUD)

Intracerebroventricular infusion of angiotensin AT2 receptor agonist novokinin aggravates some diabetes-mellitus-induced alterations in wistar rats

This dynamic, conceptualized as the Diet-Microbiome-Metabolome-Disease axis, functions to either mitigate or exacerbate disease states

To address these questions, we studied and cell secretion in people with and without type 2 diabetes under fasting and hyperglycemic conditions in the presence and absence of exendin 9-39